Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Abnormal B-cell maturation in the bone marrow of patients with germline mutations in PIK3CD.

Literature DB >> 27697496

Abnormal B-cell maturation in the bone marrow of patients with germline mutations in PIK3CD.

Alina E Dulau Florea¹, Raul C Braylan¹, Kristian T Schafernak², Kelli W Williams³, Janine Daub³, Rakesh K Goyal⁴, Jennifer M Puck⁵, V Koneti Rao³, Stefania Pittaluga⁶, Steven M Holland³, Gulbu Uzel³, Katherine R Calvo⁷.

Abstract

Entities: Chemical Disease Gene Mutation Species

Mesh：

Substances：

Year: 2016 PMID： 27697496 PMCID： PMC5342918 DOI： 10.1016/j.jaci.2016.08.028

Source DB: PubMed Journal: J Allergy Clin Immunol ISSN： 0091-6749 Impact factor: 10.793

× No keyword cloud information.

9 in total

Review 1. PI3K in lymphocyte development, differentiation and activation.

Authors: Klaus Okkenhaug; Bart Vanhaesebroeck
Journal: Nat Rev Immunol Date: 2003-04 Impact factor: 53.106

Review 2. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) and neoplastic lymphoblasts by 4-color flow cytometry.

Authors: Robert W McKenna; Sheryl L Asplund; Steven H Kroft
Journal: Leuk Lymphoma Date: 2004-02

Review 3. The emerging mechanisms of isoform-specific PI3K signalling.

Authors: Bart Vanhaesebroeck; Julie Guillermet-Guibert; Mariona Graupera; Benoit Bilanges
Journal: Nat Rev Mol Cell Biol Date: 2010-04-09 Impact factor: 94.444

Review 4. Role of PI3K in the generation and survival of B cells.

Authors: Markus Werner; Elias Hobeika; Hassan Jumaa
Journal: Immunol Rev Date: 2010-09 Impact factor: 12.988

5. Oncogenic transformation induced by the p110beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase.

Authors: Sohye Kang; Adam Denley; Bart Vanhaesebroeck; Peter K Vogt
Journal: Proc Natl Acad Sci U S A Date: 2006-01-23 Impact factor: 11.205

6. Suppression of phosphatidylinositol 3,4,5-trisphosphate production is a key determinant of B cell anergy.

Authors: Cecille D Browne; Christopher J Del Nagro; Matthew H Cato; Hart S Dengler; Robert C Rickert
Journal: Immunity Date: 2009-11-05 Impact factor: 31.745

7. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency.

Authors: Carrie L Lucas; Hye Sun Kuehn; Fang Zhao; Julie E Niemela; Elissa K Deenick; Umaimainthan Palendira; Danielle T Avery; Leen Moens; Jennifer L Cannons; Matthew Biancalana; Jennifer Stoddard; Weiming Ouyang; David M Frucht; V Koneti Rao; T Prescott Atkinson; Anahita Agharahimi; Ashleigh A Hussey; Les R Folio; Kenneth N Olivier; Thomas A Fleisher; Stefania Pittaluga; Steven M Holland; Jeffrey I Cohen; Joao B Oliveira; Stuart G Tangye; Pamela L Schwartzberg; Michael J Lenardo; Gulbu Uzel
Journal: Nat Immunol Date: 2013-10-28 Impact factor: 25.606

8. Kinetics of hematogones in bone marrow samples from patients with non-Hodgkin lymphomas treated with rituximab-containing regimens: a flow cytometric study.

Authors: Giovanni Carulli; Virginia Ottaviano; Paola Sammuri; Cristiana Domenichini; Valentina Guerri; Martina Rousseau; Eugenio M Ciancia; Elena Ciabatti; Mario Petrini
Journal: Int J Hematol Date: 2015-05-08 Impact factor: 2.490

9. Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage.

Authors: Ivan Angulo; Oscar Vadas; Fabien Garçon; Edward Banham-Hall; Vincent Plagnol; Timothy R Leahy; Helen Baxendale; Tanya Coulter; James Curtis; Changxin Wu; Katherine Blake-Palmer; Olga Perisic; Deborah Smyth; Mailis Maes; Christine Fiddler; Jatinder Juss; Deirdre Cilliers; Gašper Markelj; Anita Chandra; George Farmer; Anna Kielkowska; Jonathan Clark; Sven Kracker; Marianne Debré; Capucine Picard; Isabelle Pellier; Nada Jabado; James A Morris; Gabriela Barcenas-Morales; Alain Fischer; Len Stephens; Phillip Hawkins; Jeffrey C Barrett; Mario Abinun; Menna Clatworthy; Anne Durandy; Rainer Doffinger; Edwin R Chilvers; Andrew J Cant; Dinakantha Kumararatne; Klaus Okkenhaug; Roger L Williams; Alison Condliffe; Sergey Nejentsev
Journal: Science Date: 2013-10-17 Impact factor: 47.728

9 in total

23 in total

1. Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency.

Authors: David Boutboul; Hye Sun Kuehn; Zoé Van de Wyngaert; Julie E Niemela; Isabelle Callebaut; Jennifer Stoddard; Christelle Lenoir; Vincent Barlogis; Catherine Farnarier; Frédéric Vely; Nao Yoshida; Seiji Kojima; Hirokazu Kanegane; Akihiro Hoshino; Fabian Hauck; Ludovic Lhermitte; Vahid Asnafi; Philip Roehrs; Shaoying Chen; James W Verbsky; Katherine R Calvo; Ammar Husami; Kejian Zhang; Joseph Roberts; David Amrol; John Sleaseman; Amy P Hsu; Steven M Holland; Rebecca Marsh; Alain Fischer; Thomas A Fleisher; Capucine Picard; Sylvain Latour; Sergio D Rosenzweig
Journal: J Clin Invest Date: 2018-06-11 Impact factor: 14.808

Review 2. Immune Dysregulation and Disease Pathogenesis due to Activating Mutations in PIK3CD-the Goldilocks' Effect.

Authors: Stuart G Tangye; Julia Bier; Anthony Lau; Tina Nguyen; Gulbu Uzel; Elissa K Deenick
Journal: J Clin Immunol Date: 2019-03-25 Impact factor: 8.317

3. Mutations in the adaptor-binding domain and associated linker region of p110δ cause Activated PI3K-δ Syndrome 1 (APDS1).

Authors: Lucie Heurtier; Hicham Lamrini; Loïc Chentout; Marie-Céline Deau; Amine Bouafia; Jérémie Rosain; Jean-Marc Plaza; Mélanie Parisot; Benoit Dumont; Delphine Turpin; Etienne Merlin; Despina Moshous; Nathalie Aladjidi; Bénédicte Neven; Capucine Picard; Marina Cavazzana; Alain Fischer; Anne Durandy; Jean-Louis Stephan; Sven Kracker
Journal: Haematologica Date: 2017-04-20 Impact factor: 9.941

Review 4. Autoimmunity and Inflammation in CVID: a Possible Crosstalk between Immune Activation, Gut Microbiota, and Epigenetic Modifications.

Authors: Silje F Jørgensen; Børre Fevang; Pål Aukrust
Journal: J Clin Immunol Date: 2018-11-21 Impact factor: 8.317

Review 5. Advances and highlights in primary immunodeficiencies in 2017.

Authors: Javier Chinen; Morton J Cowan
Journal: J Allergy Clin Immunol Date: 2018-08-29 Impact factor: 10.793

Review 6. Role of inhibitory signaling in peripheral B cell tolerance.

Authors: Andrew Getahun
Journal: Immunol Rev Date: 2022-02-06 Impact factor: 12.988

7. Effective "activated PI3Kδ syndrome"-targeted therapy with the PI3Kδ inhibitor leniolisib.

Authors: V Koneti Rao; Sharon Webster; Virgil A S H Dalm; Anna Šedivá; P Martin van Hagen; Steven Holland; Sergio D Rosenzweig; Andreas D Christ; Birgitte Sloth; Maciej Cabanski; Aniket D Joshi; Stefan de Buck; Julie Doucet; Danilo Guerini; Christoph Kalis; Ilona Pylvaenaeinen; Nicolas Soldermann; Anuj Kashyap; Gulbu Uzel; Michael J Lenardo; Dhavalkumar D Patel; Carrie L Lucas; Christoph Burkhart
Journal: Blood Date: 2017-09-29 Impact factor: 22.113